ReviewClinical and experimental nephrology2026
Season-adaptive blood pressure management in older adults with CKD: a practical review.
Review in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blood pressure management in chronic kidney disease (CKD) is often approached as a relatively stable, year-round therapeutic task. In older adults, however, this assumption may be misleading. During warm weather, seasonal declines in blood pressure may interact with frailty, impaired thirst response, orthostatic vulnerability, reduced renal autoregulatory reserve, reduced intake, and fixed-dose antihypertensive prescribing, thereby increasing the risk of symptomatic hypotension, falls, volume depletion, hypoperfusion-related acute kidney injury (AKI), and interruption of organ-protective therapy. Despite this vulnerability, antihypertensive therapy may remain insufficiently reassessed across seasons, with limited attention to dynamic changes in home blood pressure, body weight, symptoms, and kidney function. In this practical review, we examine the clinical rationale for season-adaptive blood pressure management in older adults with CKD. We discuss why this population is particularly susceptible to seasonal over-lowering of blood pressure and kidney hypoperfusion, how this vulnerability may differ across CKD phenotypes, and why fixed prescribing may become maladaptive in routine care. We summarize pragmatic indicators of emerging risk, including home blood pressure trends, diurnal blood pressure patterns when relevant, body weight assessment at each clinic visit, body weight trajectory over time, orthostatic symptoms and blood pressure changes, and serial serum creatinine and estimated glomerular filtration rate measurements. We also address the supportive but limited role of urinary markers such as urinary albumin-creatinine ratio and spot urinary sodium indices. A season-adaptive approach may help reduce avoidable hypotension and hypoperfusion-related AKI while supporting the safer and more sustainable use of organ-protective therapy in older adults with CKD.
Indexed as
Identifiers
42149344What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.